156 related articles for article (PubMed ID: 38229101)
1. Effect of non-surgical periodontal therapy on CD14 + CD16+ monocyte counts in peripheral blood samples: a clinical interventional study.
Jagannathan R; Balaji TM; Rao SR; Alosaimi MS; Patil S; Siurkel Y; Cicciù M; Minervini G
BMC Oral Health; 2024 Jan; 24(1):94. PubMed ID: 38229101
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the proportion of non-classic (CD14+CD16+) monocytes/macrophages in peripheral blood and gingiva of healthy individuals and patients with chronic periodontitis.
Jagannathan R; Lavu V; Rao SR
J Periodontol; 2014 Jun; 85(6):852-8. PubMed ID: 24001047
[TBL] [Abstract][Full Text] [Related]
3. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilic asthma features increased airway classical monocytes.
Niessen NM; Baines KJ; Simpson JL; Scott HA; Qin L; Gibson PG; Fricker M
Clin Exp Allergy; 2021 Feb; 51(2):305-317. PubMed ID: 33301598
[TBL] [Abstract][Full Text] [Related]
5. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
6. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
8. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
9. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment.
Venturini J; Cavalcante RS; Golim Mde A; Marchetti CM; Azevedo PZ; Amorim BC; Arruda MS; Mendes RP
BMC Infect Dis; 2014 Oct; 14():552. PubMed ID: 25314914
[TBL] [Abstract][Full Text] [Related]
11. Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood.
Rundgren IM; Bruserud Ø; Ryningen A; Ersvær E
J Immunol Methods; 2018 Oct; 461():53-62. PubMed ID: 29906454
[TBL] [Abstract][Full Text] [Related]
12. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
[TBL] [Abstract][Full Text] [Related]
13. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
14. Reduced Percentage of CD14
Kowalska W; Zarobkiewicz M; Tomczak W; Woś J; Morawska I; Bojarska-Junak A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328450
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients.
West SD; Goldberg D; Ziegler A; Krencicki M; Du Clos TW; Mold C
PLoS One; 2012; 7(12):e52406. PubMed ID: 23285029
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of peripheral blood CD14(bright) CD16+ and CD14(dim) CD16+ monocytes may contribute to the development of retinopathy in patients with juvenile onset type 1 diabetes.
Ryba-Stanisławowska M; Myśliwska J; Juhas U; Myśliwiec M
APMIS; 2015 Sep; 123(9):793-9. PubMed ID: 26200806
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Monocyte and Macrophage Homeostasis in Periodontitis.
Almubarak A; Tanagala KKK; Papapanou PN; Lalla E; Momen-Heravi F
Front Immunol; 2020; 11():330. PubMed ID: 32210958
[TBL] [Abstract][Full Text] [Related]
18. Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes.
Garibaldi S; Barisione C; Ghigliotti G; Spallarossa P; Barsotti A; Fabbi P; Corsiglia L; Palmieri D; Palombo D; Brunelli C
Mol Biol Rep; 2012 Jun; 39(6):6745-52. PubMed ID: 22311021
[TBL] [Abstract][Full Text] [Related]
19. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
Thaler B; Hohensinner PJ; Krychtiuk KA; Matzneller P; Koller L; Brekalo M; Maurer G; Huber K; Zeitlinger M; Jilma B; Wojta J; Speidl WS
Sci Rep; 2016 Jul; 6():30162. PubMed ID: 27444882
[TBL] [Abstract][Full Text] [Related]
20. ADAM17-Mediated Reduction in CD14
Waller K; James C; de Jong A; Blackmore L; Ma Y; Stagg A; Kelsell D; O'Dwyer M; Hutchins R; Alazawi W
Front Immunol; 2019; 10():1902. PubMed ID: 31507587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
